Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody

Cancer Research

Volumn 59, Issue 13, 1999, Pages 3128-3133

  Onizuka, Shozaburo ^a,b   Tawara, Isao ^a   Shimizu, Jun ^c   Sakaguchi, Shimon ^c   Fujita, Teizo ^d   Nakayama, Eiichi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; INTERLEUKIN 2 RECEPTOR ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL SUBPOPULATION; CONTROLLED STUDY; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; MOUSE; MYELOMA; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SARCOMA; TUMOR REGRESSION; TUMOR REJECTION;

EID: 0033168037     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. + effector T cells. J. Exp. Med., 54: 1295-1311, 1984.
2. + T cell-mediated immunity. J. Exp. Med., 168: 2193-2206, 1988.
3. + effector T cells during progressive growth of the P815 mastocytoma: Immunology, 54: 47-56, 1985.
4. + T suppressor cells in mice rendered unresponsive to tumor antigens by intravenous injection of irradiated tumor cells. Int. J. Cancer, 55: 338-343, 1993.
5. Uenaka, A., Ono, T., Akisawa, T., Wada, H., Yasuda, T., and Nakayama, E. Identification of a unique antigen peptide pRL1 on BALB/c RL♂ 1 leukemia recognized by cytotoxic T lymphocytes and its relation of the akt oncogene. J. Exp. Med., 180: 1599-1607, 1994.
6. Wada, H., Matsuo, M., Uenaka, A., Shimbara, N., Shimizu, K., and Nakayama, E., Rejection antigen peptides on BALB/c RL♂ 1 leukemia recognized by cytotoxic T lymphocytes: derivation from the normally untranslated 5′ region of the c-akt protooncogene activated by long terminal repeat. Cancer Res., 55: 4780-4783, 1995.
7. Matsuo, M., Wada, H., Honda, S., Tawara, I., Uenaka, A., Kanematsu, T., and Nakayama, E. Expression of multiple unique rejection antigens on murine leukemia BALB/c RL♂ 1 and the role of dominant Akt antigen for tumor escape. J. Immunol., in press, 1999.
8. Sakaguchi, S., Fukuma, K., Kuribayashi, K., and Masuda, T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med., 161: 72-82, 1985.
9. Asano, M., Toda, M., Sakaguchi, N., and Sakaguchi, S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med., 184: 387-396, 1996.
10. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol., 160: 1212-1218, 1998.
11. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol., 155: 1151-1164, 1995.
12. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med., 188: 287-296, 1998.
13. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol., 10: 1969-1980, 1998.
14. Taguchi, O., and Takahashi, T. Administration of anti-interleukin-2 receptor α antibody in vivo induces localized autoimmune disease. Eur. J. Immunol., 26: 1608-1612, 1996.
15. Dialynas, D. P., Quan, Z. S., Wall, K. A., Pierres, A., Quintans, J., Loken, M. R., Pierres, M., and Fitch, F. W. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol., 131: 2445-2451, 1983.
16. Nakayama, E., Dippold, W., Shiku, H., Oettgen, H. F., and Old, L. J. Alloantigen-induced T-cell proliferation: Lyt phenotype of responding cells and blocking of proliferation by Lyt antisera. Proc. Natl. Acad. Sci USA., 77: 2890-2894, 1980.
17. Lowenthal, J. W., Corthesy, P., Tougne, C., Lees, R., MacDonald, H. R., and Nabholz, M. High and low affinity IL-2 receptors: analysis by IL-2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61. J. Immunol., 135: 3988-3994, 1985.
18. Ortega, G., Robb, R. J., Shevach, E. M., and Malek, T. R. The murine IL-2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells. J. Immunol., 133: 1970-1975, 1984.
19. - T cell receptor-αβ phenotypes generated in CD8-depleted C57BL/6 mice. J. Immunol., 150: 4900-4910, 1993.
20. + cells in tumor rejection. Jpn. J. Cancer Res., 80: 649-654, 1989.
21. 1 mice. Int. J. Oncol., 7: 233-238, 1995.
22. Sakaguchi, S., Takahashi, T., and Nishizuka, Y. Study on cellular events in postthymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J. Exp. Med., 156: 1577-1586, 1982.
23. Moroda, T., Iiai, T., Kawachi, Y., Kawamura, Y. T., Hatakeyama, K., and Abo, T. Restricted appearance of self-reactive clones into T cell receptor intermediate cells in neonatally thymectomized mice with autoimmune disease. Eur. J. Immunol., 26: 3084-3091, 1996.
24. Wang, J., Griggs, N. D., Tung, K. S., and Klein, J. R. Dynamic regulation of gastric autoimmunity by thyroid hormone. Int. Immunol., 10: 231-236, 1998.
25. Old, L. J., Boyse, E. A., and Stockert, E. Antigenic properties of experimental leukemias. I. Serological studies in vitro with spontaneous and radiation-induced leukemias. J. Natl. Cancer Inst., 31: 977-986, 1963.
26. Stockert, E., DeLeo, A. B., O'Donnell, P. V., Obata, Y., and Old, L. J. A new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody. J. Exp. Med., 149: 200-215, 1979.
27. Nakayama, E., Shiku, H., Takahashi, T., Oettgen, H. F., and Old, L. J. Definition of a unique cell surface antigen of mouse leukemia RL♂ 1 by cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA, 76: 3486-3490, 1979.
28. Gorer, P. A. Studies in antibody response of mice to tumor inoculation. Br. J. Cancer, 4: 372-379, 1950.
29. Potter, M. The plasma cell tumors and myeloma protein of mice. In: H. Busch (ed.), Methods in Cancer Research, pp. 106-157. New York: Academic Press, Inc., 1967.
30. Old, L. J., Boyse, E. A., Clarke, D. A., and Carswell, E. A. Antigenic properties of chemically induced tumors. Ann. NY Acad. Sci., 101: 80-106, 1962.
31. DeLeo, A. B., Shiku, H., Takahashi, T., John, M., and Old, L. J. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma. J. Exp. Med., 146: 720-734, 1977.